Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Misses Q4 EPS by 27c

February 28, 2022 4:13 PM EST

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q4 EPS of ($0.96), $0.27 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

... More